19,906 Shares in Bath & Body Works, Inc. $BBWI Bought by DRW Securities LLC

Key Points

• DRW Securities LLC acquired 19,906 shares of Bath & Body Works, valued at approximately $604,000, in the first quarter, contributing to institutional investors holding 95.14% of the company's stock.
• The company's stock price opened at $29.23, with a market cap of $6.03 billion and a P/E ratio of 8.67, facing a year-over-year revenue decline of 0.8%.
• Bath & Body Works declared a quarterly dividend of $0.20, which will be paid on September 5th, representing an annual yield of 2.7%.

DRW Securities LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 19,906 shares of the company's stock, valued at approximately $604,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Bath & Body Works by 38.9% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after acquiring an additional 11,681 shares during the period. Merit Financial Group LLC bought a new stake in shares of Bath & Body Works during the 1st quarter worth approximately $714,000. Nuveen Asset Management LLC lifted its holdings in shares of Bath & Body Works by 3.7% during the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after acquiring an additional 27,136 shares during the period. Assenagon Asset Management S.A. lifted its holdings in shares of Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after acquiring an additional 1,606,988 shares during the period. Finally, Tremblant Capital Group bought a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $6,891,000. Institutional investors own 95.14% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Wells Fargo & Company raised their price objective on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Citigroup reduced their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. UBS Group decreased their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a report on Friday, August 29th. Finally, The Goldman Sachs Group decreased their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of "Moderate Buy" and an average price target of $41.62.

Bath & Body Works Price Performance

NYSE BBWI traded down $2.38 during trading hours on Friday, reaching $29.49. The company's stock had a trading volume of 10,016,218 shares, compared to its average volume of 5,680,477. The firm has a fifty day simple moving average of $30.73 and a 200-day simple moving average of $30.58. The stock has a market cap of $6.08 billion, a P/E ratio of 8.75, a P/E/G ratio of 1.09 and a beta of 1.49. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.37. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm's quarterly revenue was down .8% on a year-over-year basis. During the same quarter last year, the business earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.